Scotiabank initiated coverage on Concentrix with a new price target
$CNXC
Computer Software: Prepackaged Software
Technology
Scotiabank initiated coverage of Concentrix with a rating of Sector Outperform and set a new price target of $120.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/3/2024 | $70.00 | Outperform | Robert W. Baird |
| 8/28/2024 | $65.00 → $85.00 | Underperform → Neutral | BofA Securities |
| 3/27/2024 | $85.00 → $60.00 | Neutral → Underperform | BofA Securities |
| 9/6/2023 | $70.00 | Neutral | Redburn Atlantic |
| 8/24/2023 | $120.00 | Sector Outperform | Scotiabank |
| 6/29/2023 | Buy → Neutral | BofA Securities | |
| 4/12/2023 | $150.00 | Buy | Canaccord Genuity |
Delivers revenue growth at the high end of previous guidance range for the quarterReturns $220 million to shareholders in fiscal 2024 through share repurchases and dividendsGains market traction with new iX GenAI productivity applicationsIntroduces 2025 guidance indicating revenue growth, margin and free cash flow expansionIncreases share repurchase authorization to $600 million NEWARK, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, today announced financial results for the fiscal fourth quarter and fiscal year ended November 30, 2024. Three Months Ended Fiscal Year Ended November 30, 2024 November 30,
NEWARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, plans to announce its fourth quarter and full year fiscal 2024 financial results after market close on Wednesday, January 15, 2025. The Company also plans to host a conference call and webcast with the investment community to discuss the financial results on Wednesday, January 15, 2025, at 5:00 pm, Eastern Time. The live conference call webcast will be available in listen-only mode in the Investor Relations section of the Concentrix website under "Events and Presentations" athttps://ir.concentrix.com/events-and-presentations. A replay will also be available on t
Delivers revenue above the midpoint of guidance and profit within guidance rangeReturns $60 million to shareholders in the quarter through share repurchases and dividends and raises quarterly dividend by 10%Introduces iX Hello™, the Company's first commercial product launch, reflecting the Company's accelerated AI investments NEWARK, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, today announced financial results for the fiscal third quarter ended August 31, 2024. Three Months Ended August 31, 2024 August 31, 2023 ChangeRevenue ($M)$2,387.4 $1,632.8 46.2%Operating income ($M)$153.
8-K - Concentrix Corp (0001803599) (Filer)
8-K - Concentrix Corp (0001803599) (Filer)
144 - Concentrix Corp (0001803599) (Subject)
NEWARK, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a leading global provider of customer experience (CX) services and technologies, today announced the arrival of Ryan Peterson as Executive Vice President and Chief Product Officer. Ryan will join the Concentrix Global Executive Team and report directly to Chris Caldwell, President and CEO. As Chief Product Officer, Ryan's mission will be to design, develop and deploy innovative products at scale across clients and internal operations. Ryan's team will focus on GenAI powered solutions that leverage Concentrix' domain expertise to enhance customer experiences, as well as improve the productivity of Co
SC 13G/A - Concentrix Corp (0001803599) (Subject)
SC 13D/A - Concentrix Corp (0001803599) (Subject)
SC 13G/A - Concentrix Corp (0001803599) (Subject)
Delivers revenue growth at the high end of previous guidance range for the quarterReturns $220 million to shareholders in fiscal 2024 through share repurchases and dividendsGains market traction with new iX GenAI productivity applicationsIntroduces 2025 guidance indicating revenue growth, margin and free cash flow expansionIncreases share repurchase authorization to $600 million NEWARK, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, today announced financial results for the fiscal fourth quarter and fiscal year ended November 30, 2024. Three Months Ended Fiscal Year Ended November 30, 2024 November 30,
NEWARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, plans to announce its fourth quarter and full year fiscal 2024 financial results after market close on Wednesday, January 15, 2025. The Company also plans to host a conference call and webcast with the investment community to discuss the financial results on Wednesday, January 15, 2025, at 5:00 pm, Eastern Time. The live conference call webcast will be available in listen-only mode in the Investor Relations section of the Concentrix website under "Events and Presentations" athttps://ir.concentrix.com/events-and-presentations. A replay will also be available on t
Chris Caldwell, President and CEO of Concentrix, to discuss AI's transformative impact on the customer experienceCompany to showcase leading-edge technologies at Stand 0404-16, FIL1 Pavilion 1 NEWARK, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, announced today that it will offer new insights into how AI and intelligent experiences are reshaping industries at Web Summit 2024, the world's premier tech conference in Lisbon, Portugal November 11-14. Chris Caldwell, President and CEO of Concentrix, will hold a fireside chat on the Corporate Innovation Stage (Pavilion 4, stage 14) on November 14 at 12pm CET on "Why Cu
4 - Concentrix Corp (0001803599) (Issuer)
4 - Concentrix Corp (0001803599) (Issuer)
4 - Concentrix Corp (0001803599) (Issuer)
4 - Concentrix Corp (0001803599) (Issuer)
4 - Concentrix Corp (0001803599) (Issuer)
4 - Concentrix Corp (0001803599) (Issuer)
Robert W. Baird initiated coverage of Concentrix with a rating of Outperform and set a new price target of $70.00
BofA Securities upgraded Concentrix from Underperform to Neutral and set a new price target of $85.00 from $65.00 previously
BofA Securities downgraded Concentrix from Neutral to Underperform and set a new price target of $60.00 from $85.00 previously